Hello,
Welcome to
- One Medical's CEO explains why the primary-care company is buying Iora;
- 8 charts shared by the CDC show how powerful Pfizer's vaccine is against COVID-19;
- How to use an at-home coronavirus test.
If you're new to this newsletter, sign up here. Comments, tips? Email me at lramsey@insider.com or tweet @lydiaramsey125. Let's get to it...
Happy September! A quick note: I linked to the wrong article yesterday about women taking out their own IUDs after doctors refused to do it. You can read that article here.
One Medical is making a $1.4 billion bet on eldercare pioneer Iora. CEO Amir Rubin tells us why.
- Primary care company
One Medical completed its $1.4 billion acquisition of Iora Health on Wednesday. - One Medical's CEO and Iora's founder shared their vision in an interview.
- They're building a primary-care company that treats patients from when they're young to when they age into Medicare.
Read more from the conversation>>
CDC shares 8 new charts that show how powerful Pfizer's vaccine is against COVID-19 and the Delta variant
- On Monday, independent experts to the
CDC voted unanimously to recommendPfizer 'svaccine to everyone over 16. - Their decision was data-driven, and factored in both the risks and benefits of vaccination.
- They reviewed graphs and tables showing that, while vaccinated people can get mild infections, Pfizer's vaccine does a great job keeping people alive and out of the hospital.
How to get at-home coronavirus tests, and how to use them correctly
- At-home coronavirus tests are in high demand amidst the Delta surge.
- Most home kits are rapid antigen tests, which are quick and cheap but not as sensitive as PCR.
- PCR testing is the current "gold standard," which you can get delivered but it usually takes place in a lab.
Here's what you need to know>>
More stories we're reading:
- Even with the Delta variant, the ability of COVID-19 vaccines to prevent hospitalization hasn't significantly dropped, CDC scientist says (Insider)
- Mental health startup Alma raised $50 million at around a $500 million valuation (Forbes)
- Prescriptions for ivermectin - a deworming drug - surged to 24 times their pre-pandemic levels as people baselessly take it as a COVID-19 cure (Insider)
- J&J's HIV vaccine failed in its first trial looking at how well it worked to prevent infections (Stat News)
- Lydia